A high plasma renin activity (PRA) has previously been related to several cardiovascular risk factors as well as to later cardiovascular events. As insulin resistance has been suggested as the unifying factor in the insulin resistance metabolic syndrome, insulin resistance was evaluated by the euglycaemic hyperinsulinaemic clamp technique in 50 untreated hypertensive subjects in whom PRA and serum aldosterone were measured together with lipids and an intravenous glucose tolerance test (IVGTT).
Introduction
During the last decade much attention has been paid to the fact that several risk factors for the development of cardiovascular diseases such as hypertension, dyslipidaemia with low levels of HDL-cholesterol and hypertriglyceridaemia, insulin resistance with hyperinsulinaemia and abdominal obesity, tend to cluster in the same individuals. [1] [2] [3] This clustering of risk factors has been named 'syndrome X' or 'the insulin resistance metabolic syndrome', as insulin resistance has been suggested to be a common link in this syndrome. 4 For more than two decades it has been obvious that patients with essential hypertension could present with a very divergent activity of the reninaldosterone system. 5 It has also been shown that a high plasma renin activity (PRA) is a powerful cardiovascular risk factor independently of other known risk factors. 6, 7 Although other studies have shown associations between the renin-aldosterone system and metabolic cardiovascular risk factors, [8] [9] [10] [11] [12] no study has evaluated if a relationship exists between direct measurements of insulin sensitivity and this hormonal system in hypertensive patients. The present study was therefore undertaken in a sample of patients with Correspondence: Lars Lind, Department of Medicine, University Hospital, S-751 85 Uppsala, Sweden Received 5 January 1998; revised 27 February 1998; accepted 13 March 1998 well as to fasting insulin (r = 0.32, P Ͻ 0.05) and to insulin at 60 min at the IVGTT (r = 0.30, P Ͻ 0.05), but not to other risk factors. Serum aldosterone was not related to any of the metabolic risk factors.
In conclusion, the present investigation showed that insulin resistance is associated with elevated levels of PRA in patients with untreated essential hypertension. It thus seems as if a high activity in the renin system should be included in the disturbances included in the insulin resistance metabolic syndrome, a syndrome with a major impact on future cardiovascular events.
essential hypertension in whom both the euglycaemic hyperinsulinaemic clamp procedure to evaluate insulin resistance and an intravenous glucose tolerance test were performed together with determinations of PRA and serum aldosterone.
Materials and methods
Patients were recruited by advertisements in the local newspapers. At an initial screening visit patients received oral and written information about the study and gave informed consent. Secondary hypertension was excluded by medical history, physical examination and laboratory tests. Patients then received single-blind placebo for 4 -6 weeks with blood pressure (BP) measurements every week for later inclusion in a drug treatment trial. If during this period they had a diastolic BP (DBP) of 95-114 mm Hg on two consecutive occasions they were included in the present study. However, at the time of collection of blood samples for PRA and other metabolic variables, five of the patients showed a DBP between 90 and 95 mm Hg.
To reduce the risk of carry-over effects from previous anti-hypertensive medication, no investigations were performed until 4 weeks after discontinuation of the patient's regular medication in the 50 patients enrolled in the study (35 men and 15 women).
Blood pressure measurements
Office BP and heart rate were measured twice in the supine as well as standing position by trained personnel. Cuff sizes of 12×35 or 15×45 cm were used depending on the arm circumference.
Ambulatory BP was measured during 24 h (Accutracker II, Suntech Medical Instr, USA) and the mean of all recordings during that period was used.
Insulin sensitivity measurements
Whole body sensitivity to insulin was measured by the euglycaemic hyperinsulinaemic clamp procedure according to DeFronzo et al 13 with minor modifications. Insulin (Actrapid Human ® , Novo, Copenhagen, Denmark) was infused at a rate of 56 mU/(min × m 2 body surface area) for 2 h. The amount of glucose infused to maintain the target glucose level during the last 60 min was defined as glucose uptake (M; mg × kg
). Adjustment for the steady-state insulin concentration defined the insulin sensitivity index (M/I; mg × min
).
Intravenous glucose tolerance test (IVGTT)
Each patient's response to an intravenous glucose load was assessed by a 90-min intravenous glucose tolerance test. The glucose load was an intravenous injection within 1.5 min of 300 mg glucose per kg of body weight in a 50% glucose solution. Insulin was assayed in EDTA plasma in duplicate using an enzymatic-immunological assay (Enzymmun ® , Boehringer Mannheim, Germany) performed in an ES300 automatic analyser (Boehringer Mannheim, Germany). The mean fasting plasma glucose and insulin values were calculated from three blood samples drawn 5 min apart prior to the injection of glucose. Peak insulin response was defined as the mean of insulin values measured in the samples drawn at 4, 6, and 8 min. Insulin was also determined after 60 min.
Lipid and lipoprotein measurement
Cholesterol and triglyceride concentrations in serum were assayed by enzymatic techniques (Instrumentation Laboratories, Lexington, MA, USA) in a Monarch 2000 centrifugal analyser. The lipoprotein fractions were separated by a combination of ultracentrifugation and precipitation. Very-low-density lipoproteins (VLDL) were separated at a density of 1.006 kg/l. The bottom fraction, containing low-density lipoproteins (LDL) and high-density lipoproteins (HDL) were separated by precipitation with magnesium chloride/phosphotungstate.
PRA and serum aldosterone
Blood samples for measurement of PRA and aldosterone were drawn in the morning after an overnight fast after 1 h of rest in the supine position. The dietary intake of sodium was not standardised. Measurements of PRA were based upon radioimmunoassay of angiotensin-I generated by endogenous renin and renin substrate. Serum aldosterone was measured by a radioimmunoassay.
Anthropometric measurements
Height was measured to the nearest whole centimetre and body weight was measured to the nearest 100 g. The body mass index (BMI) was calculated as the ratio of the weight in kg to the square of the height in metres.
Statistics
Pearson's correlation coefficient was used when PRA or serum aldosterone were related to the cardiovascular risk factors. Log transformation was performed if variables were not normally distributed (PRA, serum triglycerides and different measurements of insulin). Multiple regression analyses in a forward stepwise fashion were performed to evaluate were the influence of confounding variables, such as age, sex or BMI. P Ͻ 0.05 was used as entry criterion in the models. P Ͻ 0.05 was regarded as significant and two-tailed significant levels are given.
Results
Means and standard deviation for studied variables and basic characteristics are given in Table 1 .
As shown in Table 2 , PRA was significantly correlated with insulin sensitivity, as measured by glucose uptake during the euglycaemic hyperinsulinaemic clamp, both when expressed as the M-value and as M/I-value (Figure 1) . PRA was furthermore significantly correlated to fasting insulin ( Figure 2 ) and insulin at 60 min at the IVGTT. These relationships were still significant even when the patient with the highest PRA value (3.5 g/l/h) was excluded from the analysis. No other significant relationship between PRA and other cardiovascular risk factors was seen. Except for a relationship between DBP and serum aldosterone no significant relationships between the circulating levels of this hormone and other risk factors were seen.
The relationships between PRA and insulin sensitivity (P Ͻ 0.05), fasting insulin (P Ͻ 0.05) and insulin during the IVGTT (P Ͻ 0.05) were still significant after the influence of age, sex, BMI and BP were taken into account in the multiple regression analyses. The relationship between PRA and insulin sensitivity was very similar in men (r = −0.31) and women (r = −0.29). 
Discussion
The present study showed that insulin resistance was related to elevated levels of PRA, when evaluated by the euglycaemic hyperinsulinaemic clamp. Furthermore, similar relationships were obtained when indirect measurements of insulin resistance were used, such as fasting hyperinsulinaemia and elevated insulin levels during the IVGTT.
Although it has previously been shown by ourselves, 8 and other investigators, [9] [10] [11] [12] that high levels of PRA are related to hyperinsulinaemia, this is the first study to establish this relationship in untreated patients with essential hypertension with direct measurements of insulin sensitivity. This approach has previously been used in healthy normotensive volunteers with similar results.
14 In the study performed in normotensive subjects PRA was furthermore related to serum levels of triglycerides. Only a weak tendency for such a relationship could be seen in the present study, as well as in our previous study in a separate sample of untreated hypertensive subjects. 8 In a previous study, Goodfriend and co-workers 10 suggested that high aldosterone levels may be a link between dyslipidaemia, insulin resistance and hypertension based on findings of an inverse relationship between plasma aldosterone and HDLcholesterol and positive correlations between plasma aldosterone and insulin and triglycerides. In the present study no relationships between serum levels of aldosterone and any of the metabolic cardiovascular risk factors could be seen, although a tendency towards an inverse relationship between serum aldosterone and HDL-cholesterol was found in accordance with our previous study. 8 The fact that salt intake was not controlled in the present study might explain why the correlations between serum aldosterone and metabolic cardiovascular risk factors did not reach statistical significance.
The mechanisms connecting high PRA and insulin resistance are not known. It has been shown by several authors that during acute hyperinsulinaemia, as induced by the euglycaemic hyperinsulinaemic clamp, PRA, but not serum levels of aldosterone is increased. 15, 16 The reason for this elevation in PRA might be the concomitant rise in circulating levels of catecholamines during hyperinsulinaemia. It seems less likely that an increased activity of plasma renin directly would impair insulin sensitivity, as infusion of angiotensin-II in healthy volunteers resulted in an increase in insulin sensitivity. 17, 18 On the other hand, long-term treatment with the ACE inhibitor captopril in hypertensive subjects resulted in a sustained improvement in insulin sensitivity. 19 Another putative factor might be the magnesium ion. It has been shown that hypertensive subjects with high PRA have low levels of serum magnesium, 20 while on the other hand intracellular magnesium levels have been found to be inversely related to insulin sensitivity. 21 In the present study a large number of univariate correlations have been studied and some of them might therefore have turned out to be significant by chance only. However, as the major aim of this study was to confirm our previous finding of an association between high PRA levels and insulin resistance with a more accurate technique, we believe that the main finding in this study is not due to multiple testing.
